References
- Lazcano-PonceECMiquelJFMuñozNEpidemiology and molecular pathology of gallbladder cancerCA Cancer J Clin200151634936411760569
- LeganMCyclooxygenase-2, p53 and glucose transporter-1 as predictors of malignancy in the development of gallbladder carcinomasBosn J Basic Med Sci201010319219620846124
- XuWYZhangHHYangXBPrognostic significance of combined preoperative fibrinogen and CA199 in gallbladder cancer patientsWorld J Gastroenterol201824131451146329632426
- HuMTWangJHYuYTumor suppressor LKB1 inhibits the progression of gallbladder carcinoma and predicts the prognosis of patients with this malignancyInt J Oncol20185331215122630015925
- ChenYWuFSaitoEAssociation between type 2 diabetes and risk of cancer mortality: a pooled analysis of over 771,000 individuals in the Asia cohort ConsortiumDiabetologia20176061022103228265721
- SheblFMAndreottiGRashidADiabetes in relation to biliary tract cancer and stones: a population-based study in Shanghai, ChinaBr J Cancer2010103111511920517308
- GiovannucciEHarlanDMArcherMCDiabetes and cancer: a consensus reportDiabetes Care20103371674168520587728
- DoSKJeongJYLeeSYGlucose transporter 1 gene variants predict the prognosis of patients with early-stage non-small cell lung cancerAnn Surg Oncol201825113396340330062472
- LamkinDMSpitzDRShahzadMMGlucose as a prognostic factor in ovarian carcinomaCancer200911551021102719156916
- ParkSMLimMKShinSAYunYHImpact of prediagnosis smoking, alcohol, obesity, and insulin resistance on survival in male cancer patients: National Health Insurance Corporation StudyJ Clin Oncol200624315017502417075121
- KawamuraTKusakabeTSuginoTExpression of glucose transporter-1 in human gastric carcinoma: association with tumor aggressiveness, metastasis, and patient survivalCancer200192363464111505409
- NoguchiYMaratDSaitoAExpression of facilitative glucose transporters in gastric tumorsHepatogastroenterology199946282683268910522065
- HaberRSRathanAWeiserKRGLUT1 glucose transporter expression in colorectal carcinoma: a marker for poor prognosisCancer199883134409655290
- LeganMTevžičSTolarALuzarBMaroltVFGlucose transporter-1 (GLUT-1) immunoreactivity in benign, premalignant and malignant lesions of the gallbladderPathol Oncol Res2011171616620512538
- PangQZhangLQWangRTPlatelet to lymphocyte ratio as a novel prognostic tool for gallbladder carcinomaWorld J Gastroenterol201521216675668326074706
- KanthanRSengerJLAhmedSKanthanSCGallbladder cancer in the 21st centuryJ Oncol2015201510126
- ZhuAXHongTSHezelAFKoobyDACurrent management of gallbladder carcinomaOncologist201015216818120147507
- CaiQLuoXLiangYFasting blood glucose is a novel prognostic indicator for extranodal natural killer/T-cell lymphoma, nasal typeBr J Cancer2013108238038623299534
- LuoJChenYJChangLJFasting blood glucose level and prognosis in non-small cell lung cancer (NSCLC) patientsLung Cancer201276224224722112292
- HundalRShafferEAGallbladder cancer: epidemiology and outcomeClin Epidemiol201469910924634588
- ShenHXSongHWXuXJClinical epidemiological survey of gallbladder carcinoma in northwestern China, 2009-2013: 2379 cases in 17 centersChronic Dis Transl Med201731606629063057
- HanahanDWeinbergRAHallmarks of cancer: the next generationCell2011144564667421376230
- SuhSKimKWDiabetes and cancer: is diabetes causally related to cancer?Diabetes Metab J201135319319821785737
- GiovannucciEInsulinGEInsulin, insulin-like growth factors and colon cancer: a review of the evidenceJ Nutr200113111 Suppl3109S312011694656
- CookKDBorzokJSumreinFOplerDJEvaluation and perioperative management of the diabetic patientClin Podiatr Med Surg20193618310230446046
- HeindelJJBlumbergBCaveMMetabolism disrupting chemicals and metabolic disordersReprod Toxicol20176833327760374
- MasurKVetterCHinzADiabetogenic glucose and insulin concentrations modulate transcriptome and protein levels involved in tumour cell migration, adhesion and proliferationBr J Cancer2011104234535221179032
- DuanWShenXLeiJHyperglycemia, a neglected factor during cancer progressionBiomed Res Int201420144176110
- YoungCDAndersonSMSugar and fat – that’s where it’s at: metabolic changes in tumorsBreast Cancer Res200810120218304378
- RudlowskiCMoserMBeckerAJGLUT1 mRNA and protein expression in ovarian borderline tumors and cancerOncology200466540441015331928
- KrzeslakAWojcik-KrowirandaKFormaEExpression of GLUT1 and GLUT3 glucose transporters in endometrial and breast cancersPathol Oncol Res201218372172822270867
- KroneCAElyJTControlling hyperglycemia as an adjunct to cancer therapyIntegr Cancer Ther200541253115695475
- RyuTYParkJSchererPEHyperglycemia as a risk factor for cancer progressionDiabetes Metab J201438533033625349819
- PiątkiewiczPCzechAGlucose metabolism disorders and the risk of cancerArch Immunol Ther Exp (Warsz)201159321523021448680
- HanJZhangLGuoHGlucose promotes cell proliferation, glucose uptake and invasion in endometrial cancer cells via AMPK/mTOR/S6 and MAPK signalingGynecol Oncol2015138366867526135947
- ChenJYuYChenXmiR-139-5p is associated with poor prognosis and regulates glycolysis by repressing PKM2 in gallbladder carcinomaCell Prolif2018516e1251030105813